What can MyoStrain® do for you?

MyoStrain helps certified physicians detect, manage and even predict early heart dysfunction.¹

MyoStrain is rapid and safe

MyoStrain provides a 10-minute non-invasive exam without needles, pharmacological stressors, contrast agents, exposure to radiation or breath-holding

MyoStrain is a direct and accurate assessment

MyoStrain enables the improved identification of asymptomatic patients with early heart dysfunction²

MyoStrain helps detect cardiac risk

MyoStrain helps your MyoStrain-certified physician identify your risk of developing adverse cardiac events and create a proactive treatment plan that's right for you³

MyoStrain is a personalized approach to heart care

MyoStrain helps physicians monitor the effects of your therapy, optimize your treatment plan over time, and protect your heart long term³

What makes MyoStrain Unique?

  • The heart is a powerful and dynamic muscular system that uses compensatory mechanisms to help make sure the body receives the blood and oxygen it needs to function.⁴
  • These compensatory mechanisms force stronger areas of the heart to compensate for the weaker areas (heart dysfunction).
  • As a result, the heart appears healthy as a whole, but the weak areas of the heart remain undetected, eventually leading to heart damage.
  • Unlike other heart assessments, MyoStrain uses advanced diagnostic techniques to help clinicians to see which areas of the heart are weak and which are strong.⁵
  • This knowledge allows clinicians to focus on detecting heart dysfunction early to take action before damage occurs.

Why is early detection so important?

A clinical study showed MyoStrain was able to detect asymptomatic heart dysfunction in patients suspected of heart failure. This helped cardiologists to assess their risk early and monitor the effectiveness of their treatment over time.³


[1] Guisca S, et al. Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardial Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-Up. Circulation. 2021;14:e012459 [2] Steen, H., Giusca, S., Montenbruck M, et al. (2021). Left and right ventricular strain using fast strain-encoded cardiovascular magnetic resonance for the diagnostic classification of patients with chronic non-ischemic heart failure due to dilated, hypertrophic cardiomyopathy or cardiac amyloidosis. J Cardiovasc Magn Reson 23, 45. https://doi.org/10.1186/s12968-021-00711-w [3] Korosoglou G, et al. J Am Coll Cardiol Cardiovasc Imaging. Jan 13,2021. DOI: 10.1016/j.jcmg.2020.10.024. [4] University of Michigan Health. Heart Failure: Compensation by the Heart and Body. https://www.uofmhealth.org/health-library/aa86963 [5] Korosoglou G, et al. Strain-encoded Magnetic resonance: A Method for the Assessment of Myocardial Deformation. ESC Heart Failure. 2019: 1-19. doi:10.1002/ehf2.12442.